Unknown

Dataset Information

0

Xenogeneic and Stem Cell-Based Therapy for Cardiovascular Diseases: Genetic Engineering of Porcine Cells and Their Applications in Heart Regeneration.


ABSTRACT: Cardiovascular diseases represent a major health concern worldwide with few therapy options for ischemic injuries due to the limited regeneration potential of affected cardiomyocytes. Innovative cell replacement approaches could facilitate efficient regenerative therapy. However, despite extensive attempts to expand primary human cells in vitro, present technological limitations and the lack of human donors have so far prevented their broad clinical use. Cell xenotransplantation might provide an ethically acceptable unlimited source for cell replacement therapies and bridge the gap between waiting recipients and available donors. Pigs are considered the most suitable candidates as a source for xenogeneic cells and tissues due to their anatomical and physiological similarities with humans. The potential of porcine cells in the field of stem cell-based therapy and regenerative medicine is under intensive investigation. This review outlines the current progress and highlights the most promising approaches in xenogeneic cell therapy with a focus on the cardiovascular system.

SUBMITTER: Galow AM 

PROVIDER: S-EPMC7766969 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Xenogeneic and Stem Cell-Based Therapy for Cardiovascular Diseases: Genetic Engineering of Porcine Cells and Their Applications in Heart Regeneration.

Galow Anne-Marie AM   Goldammer Tom T   Hoeflich Andreas A  

International journal of molecular sciences 20201218 24


Cardiovascular diseases represent a major health concern worldwide with few therapy options for ischemic injuries due to the limited regeneration potential of affected cardiomyocytes. Innovative cell replacement approaches could facilitate efficient regenerative therapy. However, despite extensive attempts to expand primary human cells in vitro, present technological limitations and the lack of human donors have so far prevented their broad clinical use. Cell xenotransplantation might provide an  ...[more]

Similar Datasets

| S-EPMC5867037 | biostudies-other
| S-EPMC7347786 | biostudies-literature
| S-EPMC10874864 | biostudies-literature
| S-EPMC4829265 | biostudies-literature
| S-EPMC3483066 | biostudies-literature
| S-EPMC6430161 | biostudies-literature
| S-EPMC3692981 | biostudies-other
| S-EPMC5337882 | biostudies-literature
| S-EPMC4863075 | biostudies-literature
| S-EPMC7066852 | biostudies-literature